Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-31

Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigating the use of umbilical cord-derived mesenchymal stem cells for treating primary biliary cirrhosis (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Primary Biliary Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN